RELATLIMAB
UNII AF75XOF6W3

Substance Identification & Data

This profile provides standardized clinical and technical data for Relatlimab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) AF75XOF6W3.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1673516-98-7 and the RxNorm Concept ID (RxCUI) 2596773. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

AF75XOF6W3

CAS Registry Number

1673516-98-7

RxNorm Concept ID

2596773

Detailed Substance Profile

Preferred Name

RELATLIMAB

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

AF75XOF6W3

The specific atomic composition represented as a molecular structure string.

NCI Thesaurus

C111999

National Cancer Institute reference terminology for clinical and research data.

INN ID

10735

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

CD-174

Identifier assigned by the United States Adopted Names Council.

Substance Type

protein

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Relatlimab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.